Clinical Trial

Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity

Study acronym: SHOT
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To compare the efficacy and safety of sacubitril/Allisartan versus amlodipine in the antihypertensive treatment of overweight/obese patients with primary hypertension
Trial Details
NCT Number NCT07241338
Lead Sponsor Jing Liu
Conditions Hypertension
Enrollment 104 participants
Start Date 2025-11
Primary Completion 2026-11 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-11-21